| UHC Medicaid Medical & Drug | Gonadotropin Releasing Hormone Analogs – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Ilaris® (Canakinumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Immune Globulin (IVIG and SCIG) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Infliximab – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Intracanalicular and Intravitreal Corticosteroid Implants – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Intravenous Iron Replacement Therapy (Feraheme®, Injectafer®, & Monoferric®) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Kebilidi™ (Eladocagene Exuparvovec-Tneq) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Korsuva® (Difelikefalin) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Lemtrada® (Alemtuzumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Long-Acting Injectable Antiretroviral Agents for HIV – Community Plan Medical Benefit Drug Policy | 2026-04-01 |